Comprehensive Textbook of Genitourinary Oncology
http://www.100md.com
《新英格兰医药杂志》
With nearly one fourth of all solid tumors located in four organs, genitourinary oncology is proportionately underrepresented in the literature of basic science, epidemiology, clinical research, and translational research. However, this topic is well covered in medical textbooks, most of which have been urologic textbooks such as Campbell's Urology (8th ed. Philadelphia: W.B. Saunders, 2002). Recently, however, there has been an increase in multidisciplinary textbooks. In particular, this year marks the 10th anniversary of the first edition of the Comprehensive Textbook of Genitourinary Oncology as well as the release of the third edition.
The original editors, a diverse group, established the book's objectives — to serve as a resource for clinicians from various disciplines, a scientific reference for basic scientists, and a teaching guide for trainees. This newest edition stays true to these objectives and the editors aim to position it, literally, on tables in multidisciplinary clinics around the world.
For trainees in the field who are treating patients with complicated conditions, a textbook that is comprehensive and easy to consult is priceless. The academically renowned editors and contributing authors from a broad array of backgrounds have created a comprehensive work with attention given to evidence-based practice patterns. The chapter on the treatment of locally recurrent prostate cancer is well written. There is no single answer to the question of how to manage a rising prostate-specific antigen level after definitive therapy, so the authors provide the most recent data available on managing these sometimes complicated cases. In addition, the chapter on prostate biopsy serves as a how-to for the urologist and provides sufficient detail for other specialists to understand the complexities and nuances of the procedure. Important updates include discussions of docetaxel for the treatment of metastatic hormone-refractory prostate cancer and neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Unfortunately, the publication of this book preceded the publication of data on the most current therapies for renal-cell carcinoma. For example, the Food and Drug Administration recently approved two new agents for the treatment of advanced renal-cell carcinoma. Sorafenib and sunitinib are small-molecule–receptor tyrosine kinase inhibitors, selected primarily for their inhibition of vascular endothelial growth factor receptors. Another minor weakness of the Comprehensive Textbook of Genitourinary Oncology is that some introductions to various parts of the book are redundant; perhaps this is a consequence of multiple authors. Although these redundancies do not lessen the book's quality, they distract from its flow.
In addition to their competition with traditional publications, textbooks now compete with Internet sources that are likely to be updated more frequently. Therefore, the benefit of a book like this may be that it provides the historical context of the field, rather than the most current data. One of the real strengths of this book is its multidisciplinary nature. For instance, chapter 13A (on decision making regarding the treatment of early-stage prostate cancer) was written by four preeminent experts in radiation oncology, medical oncology, urology, and outcomes science; the result is a balanced discussion of approaches. Such chapters offer a blueprint for how multidisciplinary clinics might handle discussions with patients.
Daniel George, M.D.
JoEllen C. Speca, M.D.
Stephen J. Freedland, M.D.
Duke University Medical Center
Durham, NC 27705
daniel.george@duke.edu(Third edition. Edited by )
The original editors, a diverse group, established the book's objectives — to serve as a resource for clinicians from various disciplines, a scientific reference for basic scientists, and a teaching guide for trainees. This newest edition stays true to these objectives and the editors aim to position it, literally, on tables in multidisciplinary clinics around the world.
For trainees in the field who are treating patients with complicated conditions, a textbook that is comprehensive and easy to consult is priceless. The academically renowned editors and contributing authors from a broad array of backgrounds have created a comprehensive work with attention given to evidence-based practice patterns. The chapter on the treatment of locally recurrent prostate cancer is well written. There is no single answer to the question of how to manage a rising prostate-specific antigen level after definitive therapy, so the authors provide the most recent data available on managing these sometimes complicated cases. In addition, the chapter on prostate biopsy serves as a how-to for the urologist and provides sufficient detail for other specialists to understand the complexities and nuances of the procedure. Important updates include discussions of docetaxel for the treatment of metastatic hormone-refractory prostate cancer and neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Unfortunately, the publication of this book preceded the publication of data on the most current therapies for renal-cell carcinoma. For example, the Food and Drug Administration recently approved two new agents for the treatment of advanced renal-cell carcinoma. Sorafenib and sunitinib are small-molecule–receptor tyrosine kinase inhibitors, selected primarily for their inhibition of vascular endothelial growth factor receptors. Another minor weakness of the Comprehensive Textbook of Genitourinary Oncology is that some introductions to various parts of the book are redundant; perhaps this is a consequence of multiple authors. Although these redundancies do not lessen the book's quality, they distract from its flow.
In addition to their competition with traditional publications, textbooks now compete with Internet sources that are likely to be updated more frequently. Therefore, the benefit of a book like this may be that it provides the historical context of the field, rather than the most current data. One of the real strengths of this book is its multidisciplinary nature. For instance, chapter 13A (on decision making regarding the treatment of early-stage prostate cancer) was written by four preeminent experts in radiation oncology, medical oncology, urology, and outcomes science; the result is a balanced discussion of approaches. Such chapters offer a blueprint for how multidisciplinary clinics might handle discussions with patients.
Daniel George, M.D.
JoEllen C. Speca, M.D.
Stephen J. Freedland, M.D.
Duke University Medical Center
Durham, NC 27705
daniel.george@duke.edu(Third edition. Edited by )